Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients

Mostrar otras versiones (1)

There is currently a critical need to determine the efficacy of SARS-CoV-2 vaccination for immunocompromised patients. In this study, we determined the neutralizing antibody response in 160 cancer patients diagnosed with chronic lymphocytic leukemia (CLL), lung cancer, breast cancer, and various non...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Cong, Evans, John P., Reisinger, Sarah, Woyach, Jennifer, Liscynesky, Christina, Boghdadly, Zeinab El, Rubinstein, Mark P., Chakravarthy, Karthik, Saif, Linda, Oltz, Eugene M., Gumina, Richard J., Shields, Peter G., Li, Zihai, Liu, Shan-Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547525/
https://www.ncbi.nlm.nih.gov/pubmed/34704093
http://dx.doi.org/10.1101/2021.10.20.21265273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547525/
https://www.ncbi.nlm.nih.gov/pubmed/34704093
http://dx.doi.org/10.1101/2021.10.20.21265273

Ejemplares similares